FIELD: medicine. SUBSTANCE: an agent has an active component - interferon inducing agent or interferon and patient self-blood. Ratio of blood and an active component is (4:1)-(3:1) in total volume 10-8 ml. Self-blood of patient is treated with an active component extracorporeally, kept for 15-20 min and administrated to patient again by intravenously or intramuscular route. Invention promotes rapid immunoreablement of interferon system and enhances effectiveness of clinical reablement of body patient. EFFECT: improved method of therapy, enhanced effectiveness of an agent. 2 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD AND MEANS FOR STIMULATING RESISTANCE TO INFECTION | 2001 |
|
RU2191594C1 |
| METHOD OF DETERMINING INDIVIDUAL HUMAN BLOOD LEUKOCYTE DRUG SENSITIVITY | 2009 |
|
RU2423705C2 |
| SUPPOSITORIES AND METHOD OF PROPHYLAXIS AND TREATMENT OF DISEASES TRANSMITTED BY GENITAL TRACTS | 1999 |
|
RU2147873C1 |
| METHOD OF TREATING POLYPOSIS RHINOSINUSITIS | 1998 |
|
RU2140215C1 |
| METHOD FOR TREATMENT OF CHRONIC HYPERPLASTIC LARYNGITIS | 2000 |
|
RU2214249C2 |
| SUCKING PILL CONTAINING HUMAN INTERFERON AND/OR INTERFERON INDUCTOR POSSESSING ANTIVIRAL ACTIVITY | 2004 |
|
RU2277932C2 |
| METHOD FOR TREATING THE CASES OF LARYNGEAL PAPILLOMATOSIS | 1999 |
|
RU2147841C1 |
| INTERFERON INDUCING AGENT | 1998 |
|
RU2132681C1 |
| METHOD FOR SELECTING THE TYPE OF IMMUNOMODULATION THERAPY AND DETERMINING DISEASE OUTCOME ON THE BASIS OF PATIENT INTERFERON STATUS ANALYSIS | 1998 |
|
RU2159936C2 |
| METHOD FOR TREATING PATIENTS FOR VIRAL HEPATITIS C | 2002 |
|
RU2212248C1 |
